CIK 0001813814 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Definium Therapeutics, Inc.
Sign in to watch- Ticker
- DFTX
- Exchange
- Nasdaq
- Industry
- Medicinal Chemicals & Botanical Products
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- Phone
- 212-220-6633
- Business address
- ONE WORLD TRADE CENTER, SUITE 8500, NEW YORK, NY, 10007
- Former names
- Mind Medicine (MindMed) Inc.
- 4 Planned sale Chief Executive Officer sold 21,208 shares at $6.74 ($142,942)
- 4 Planned sale Chief Medical Officer sold 6,836 shares at $6.74 ($46,075)
- 4 Planned sale Chief Legal Officer sold 6,576 shares at $6.74 ($44,322)
- 4 Planned sale Chief Accounting Officer sold 2,347 shares at $6.74 ($15,819)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Chief Executive Officer acquired 350,000 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 115,000 shares (grant or award)
- 4 Grant or award Chief Legal Officer acquired 150,000 shares (grant or award)
- 4 Grant or award Chief Accounting Officer acquired 50,000 shares (grant or award)
- 4 Planned sale Chief Executive Officer sold 19,106 shares at $7.43 ($141,958)
- 4 Planned sale Chief Accounting Officer sold 2,273 shares at $7.43 ($16,888)
- 4 Planned sale Chief Medical Officer sold 6,643 shares at $7.43 ($49,357)
- 4 Planned sale Chief Legal Officer sold 4,519 shares at $7.43 ($33,576)
- 4 Open-market buy Director bought 2,500 shares at $7.17 ($17,925)
- 4 Planned sale Chief Accounting Officer sold 2,352 shares at $5.98 ($14,065)
- 4 Planned sale Chief Executive Officer sold 19,771 shares at $5.98 ($118,231)
- 4 Planned sale Chief Medical Officer sold 6,871 shares at $5.98 ($41,089)
- 4 Planned sale Chief Legal Officer sold 4,430 shares at $5.98 ($26,491)
- 4 Open-market buy Director bought 3,500 shares at $5.98 ($20,930)
Page 4 of 10 · 186 filings